The Quinidine Gluconate Extended-Rel, cataloged under National Stock Number 6505-01-157-7622, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-157-7622 |
| Primary Part Number | NDC50419-0101-50 |
| Item Name | Quinidine Gluconate Extended-Rel |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 500.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC50419-0101-50 PRIMARY | Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| QUINAGLUTE | 5/1 Secondary reference Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc |
NSN 6505-01-157-7622 is a Quinidine Gluconate Extended-Rel, manufactured by Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-157-7622 has 1 manufacturer part number on file: NDC50419-0101-50 (Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc).
Key specifications for NDC50419-0101-50: Primary Container Content Quantity: 500.000 TABLETS; Primary Container Type: BOTTLE; Special Features: LONG ACTION METHOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;; Active Medicament Medicinal Strength: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.